Table 5. Cox multivariate analysis of prognosis of patients with ARDS.
The NGS group had a better prognosis than no-NGS group (P = 0.005). Those with a shorter stay in the ICU (P = 0.037), and lower APACHE II before treatment (P = 0.016) and SOFA scores before treatment (P = 0.003) had a better prognosis.
| HR | Lower .95 | Upper .95 | P-value | |
|---|---|---|---|---|
| mNGS (yes/no) | 0.263 | 0.105 | 0.663 | 0.005* |
| Age (years) | 1.013 | 0.988 | 1.038 | 0.322 |
| Length of stay in ICU (days) | 0.888 | 0.794 | 0.993 | 0.037* |
| APACHE II score before treatment | 1.112 | 1.020 | 1.212 | 0.016* |
| SOFA score before treatment | 1.339 | 1.105 | 1.622 | 0.003* |
| Coronary heart disease (yes/no) | 1.660 | 0.556 | 4.958 | 0.364 |
| Bronchiectasis (yes/no) | 1.128 | 0.331 | 3.843 | 0.848 |
| Diabetes (yes/no) | 0.324 | 0.088 | 1.195 | 0.091 |
| Hb (g/L) | 0.993 | 0.980 | 1.006 | 0.284 |
| T.Bil (mmol/L) | 0.999 | 0.987 | 1.012 | 0.882 |
| Be | 1.063 | 0.996 | 1.133 | 0.064 |
| Use of vasoactive agent (yes/no) | 1.443 | 0.587 | 3.548 | 0.424 |
| ECMO (yes/no) | 1.212 | 0.067 | 21.764 | 0.896 |
| Cost in ICU (CNY) | 1.000 | 1.000 | 1.000 | 0.477 |
Note:
P < 0.05 was considered statistically significant.